University of California San Francisco
Give to UCSF
Many physicians are unfamiliar with how the Food and Drug Administration’s (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals
Quality of sleep, not quantity, may play a part in the development of dementia decades before symptoms start.
Cell biologist and engineer Matthew Kutys, PhD, and his team harness organoids – living tissues derived from patient tumors – to study how cancer spreads.
What a tiny grassroots program in the Tenderloin is teaching doctors about healing through human connection.
Fortified stem cells. Enhanced memory. A longevity hormone. UCSF researchers are finding out whether we can cancel – or at least delay – old age.
Thirty-two UCSF scientists are among the most influential individuals in their respective fields, according to the most recent analysis of research citations by the science and intellectual property company, Clarivate.
UCSF researchers found that regular screening is not always sufficient to prevent an advanced breast cancer diagnosis.
The UC San Francisco School of Dentistry has received a $4 million National Institutes of Health (NIH) grant to kickstart its clinical research program, in part by developing a new artificial
Personalized health and lifestyle changes such as increased exercise and socializtion can delay or even prevent memory loss for higher-risk older adults.
A previously unknown signaling cycle stemming from our sense of taste helps suppress our appetites.
New research shows that in the U.S., the longevity gap between women and men has been widening for more than a decade, with women outliving men by an average of six years.
A collaboration is between two biomedical researchers bridges the laboratory and clinic to advance the science of itch, allergy and asthma.
UCSF's Adam Boxer, MD, PhD, and Harvard neurologist Reisa Sperling, MD, review the history of clinical trials over the past 30 years in Alzheimer’s research with what was learned and how new biomarkers and clinical trial approaches are being used to find more effective treatments in a more efficient way than in the past.
UCSF experts to discuss amyloid therapies and dementia research at CTAD conference, addressing equity, novel treatments, and innovative studies.